Komori
General Meetings of Shareholders4596Kubota Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice Concerning the Determination of Agenda Items for the 11th Annual Shareholders Meeting

The Company decided to hold the 11th Annual Shareholders Meeting on 24 April 2026 and submit 5 proposals: a reduction in stated capital and disposition of other capital surplus, the election of directors, the election of an accounting auditor, stock options, and new share-based compensation.

Worth reading
53Recurring
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (11th fiscal year)
2026
Apr 24
Date and time37 days from this disclosure to the meeting
Matters for resolution5 items
  1. Reduction in the Amount of Stated Capital (Capital Reduction) and Disposition of Other Capital Surplus

  2. Election of 1 director (excluding directors who are Audit and Supervisory Committee members)

  3. Election of an Accounting Auditor

  4. Authorization for the Company's Board of Directors to Determine the Offering Terms for Subscription Rights to Shares Issued as Stock Options

  5. Determination of Compensation under the Restricted Stock Compensation Plan for Directors, excluding Directors who are Audit and Supervisory Committee Members

Director nomineeThere is 1 candidate. The number of new and outside candidates is not disclosed.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (11th fiscal year)
Date and time2:00 p.m., Friday, 24 April 2026
Matters for resolutionProposal No. 1: Reduction in the Amount of Stated Capital (Capital Reduction) and Disposition of Other Capital Surplus, Proposal No. 2: Election of 1 director (excluding directors who are Audit and Supervisory Committee members), Proposal 3: Election of an Accounting Auditor, Proposal No. 4: Authorization for the Company's Board of Directors to Determine the Offering Terms for Subscription Rights to Shares Issued as Stock Options, Proposal No. 5: Determination of Compensation under the Restricted Stock Compensation Plan for Directors, excluding Directors who are Audit and Supervisory Committee Members
Director nomineeThere is 1 candidate. The number of new and outside candidates is not disclosed.
Items this document does not state (2)
Shareholder ProposalPercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

At a meeting of the Board of Directors held on 18 March 2026, the Company resolved to hold the 11th Annual Shareholders Meeting and submit the agenda items.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Determination of Agenda Items for the 11th Annual Shareholders Meeting | Kubota Pharmaceutical Holdings Co.,Ltd. (4596) timely disclosure | Komori